A Novel Surgical Management for Male Infertility Secondary to Midline Prostatic Cyst

Gong Cheng; Bianjiang Liu; Zhen Song; Aiming Xu; Ninghong Song; Zengjun Wang

BMC Urol. 2015;15(18)

Background

Male infertility affects about 8% of couples around the world.^[1] Midline prostatic cyst (MPC), a rare but surgically correctable disease, is deemed to cause ejaculatory duct obstruction (EDO) which accounts for approximately 1–5% of male infertility.^[2] Most MPCs are nonsymptomatic. Semen analysis, transrectal ultrasonography (TRUS) and pelvic magnetic resonance imaging (MRI) can help to diagnose MPC. For treatment, cyst puncture and simple endoscopic section are widely used. However, the efficacy is often poor. The present study shows a novel surgical management for male infertility secondary to MPC.

1 2 3 4 5 6

Next Section

Table 1. The preoperative and postoperative semen parameters of 12 cases
	Preoperative		Postoperative
	Concentration (10⁶/mL)	Grade a + b (%)	Concentration (10⁶/mL)	Grade a + b (%)
Oligoasthenozoospermia 1	11	33.3	45	60.0
Oligoasthenozoospermia 2	6	12.7	21	48.5
Oligoasthenozoospermia 3	15	26.1	73	66.5
Oligoasthenozoospermia 4	2	12.3	4	11.1
Oligoasthenozoospermia 5	9	22.4	50	59.6
Azoospermia 1	0	0	21	62.3
Azoospermia 2	0	0	17	52.3
Azoospermia 3	0	0	0	0
Azoospermia 4	0	0	32	68.7
Azoospermia 5	0	0	10	45.5
Azoospermia 6^*	0	0	0	0
Azoospermia 7	0	0	43	57.9